Norris Medicines Profit & Loss Annual

Trade
BSE: 524414 | NSE: - | ISIN: INE744C01029 | Sector: Biotechnology & Drugs
18.47 -0.97 (-4.99%)Updated : 26 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 5.648.369.4412.25
Total Revenue 5.648.369.4412.25
Costof Revenue Total 2.663.365.618.74
Gross Profit 2.985.003.833.51
Selling/ General/ Admin Expenses Total 1.822.302.333.10
Research Development 13.4117.7415.7421.54
Depreciation/ Amortization 0.570.630.660.67
Total Operating Expense 6.398.0710.1714.66
Operating Income -0.760.29-0.73-2.41
Interest Inc( Exp) Net- Non- Op Total -3.70-15.00-14.82-16.34
Other Net 0.030.010.030.05
Net Income Before Taxes -1.10-1.19-2.18-3.99
Provisionfor Income Taxes 0.090.561.080.97
Net Income After Taxes -1.19-1.75-3.26-4.96
Net Income Before Extra Items -1.19-1.75-3.26-4.96
Net Income -1.19-1.75-3.26-4.96
Income Availableto Com Excl Extra Ord -1.19-1.75-3.26-4.96
Income Availableto Com Incl Extra Ord -1.19-1.75-3.26-4.96
Diluted Net Income -1.19-1.75-3.26-4.96
Diluted Weighted Average Shares 1.001.001.001.00
Diluted EPS Excluding Extra Ord Items -1.19-1.75-3.26-4.96
Diluted Normalized EPS -1.19-1.75-3.26-4.96
Other Operating Expenses Total ---0.00
Total Adjustmentsto Net Income ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,924.25+35.10(1.86%)
2,506.00+45.40(1.85%)
144.85+1.25(0.87%)
11,171.00-285.85 (-2.50%)
HomeMarketsPremiumInstant LoanMint Shorts